Artelo biosciences receives ethics approval to commence its cancer appetite recovery phase i/ii clinical study of art27.13 for treatment of cancer-related anorexia

Artelo biosciences receives ethics approval to commence its cancer appetite recovery phase i/ii clinical study (cares) of art27.13 for treatment of cancer-related anorexia.artelo biosciences - got ethics committee approval in u.k. for co's cancer appetite recovery study.artelo biosciences - intends to initially develop art27.13 as a supportive care therapy for cancer patients suffering from anorexia and weight loss.
ARTL Ratings Summary
ARTL Quant Ranking